Vertigo – the perception of apparent movement between oneself and the environment – is the second most common symptom in medicine, only exceeded by pain. It causes around 30% of people to be treated once in a lifetime – many of them permanently. However, despite its high prevalence, patients with vertigo often receive either inappropriate or inadequate treatment. Main reasons for this unacceptable situation are insufficient interdisciplinary cooperation, non-existent standards in diagnostics and therapy, the relatively rare translations of basic science findings to clinical applications, and the scarcity of prospective controlled multicenter clinical trials. Fortunately, vertigo is treatable, because the human brain is extremely adaptable and can compensate for the loss of the balance organ. The form of therapy with the best prospects for long-term success is structured balance training, which teaches our brain to process the remaining information correctly. However, like any workout, balance training must be done on a sustained basis and successes are slow. This is where EQUIVert comes into play – EQUIVert is the personal balance trainer with biofeedback for the home use. The symptoms disappear faster, the workouts can be kept shorter and the effect lasts longer – even for people who have already experienced vertigo for some time.
At GED we have put together a highly skilled team for the determination of the technological, practical and economic viability of EQUIVert with the goal of realization and market introduction. The team is led by founder and managing director Hanno Platz, who will be responsible to establish the commercialization strategy.
With experienced hardware and software developers on board, we combine extensive project management, production planning and machine-oriented software solutions experience. Our personnel have longstanding experience in quality management as well as in the assembly of high-tech components. We have filled roles in marketing and communications, business development and roles required to comply with the medical devices acts and regulations.
